Moderna

American biotechnology company

Moderna ▸ Facts ▸ Comments ▸ News ▸ Videos

Moderna, Inc. is a pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".

0 shares	Share Tweet Save Post Send

You Might Like

COVID-19: EU approves Moderna's vaccine for kids aged 12-17 years This is the second vaccine approved for use on children in Europe. The first vaccine by Pfizer/BioNTech was approved in May. DNA - Published on July 23, 2021
India offered 7.5 million doses of Moderna vaccine; no consensus on indemnity clause yet: Sources IndiaTimes - Published on July 19, 2021
India expects 3-4 million Pfizer, Moderna vaccine doses through Covax by August- sources India expects to receive 3 million to 4 million doses of the Pfizer and Moderna Covid-19 shots through the Covax facility by August, two sources said, as it tries to expand inoculations to prevent.. IndiaTimes - Published on July 7, 2021

DCGI gives emergency use nod to Moderna’s vaccine Indian pharma major Cipla will “facilitate” the import of Covid vaccines donated by US biotech major Moderna, possibly in the near future, under licence for restricted use by India’s drug.. IndiaTimes - Published on June 29, 2021
Covishield becomes collateral damage in inter-EU tussle over Chinese vaccines EMA has listed 4 vaccines, which are Comirnaty (Pfizer), Janssen, Spikevax (previously COVID-19 Vaccine Moderna), and AstraZeneca's Vaxzevria. DNA - Published on June 29, 2021